← Back to patent-cliff list
CAS 162285-31-6
methyl L-seryl-L-valinate hydrochloride
Codes: YSV-004
Application context (from source-drug indications)
Non-small cell lung cancerTyroservaltide
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Tyroservaltide | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(tert-butoxycarbonyl)-L-serine→methyl L-valinate hydrochloride→methyl (tert-butoxycarbonyl)-L-seryl-L-valinate→methyl L-seryl-L-valinate hydrochloride→(S)-2-((tert-butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid→methyl (tert-butoxycarbonyl)-L-tyrosyl-L-seryl-L-valinate→(tert-butoxycarbonyl)-L-tyrosyl-L-seryl-L-valine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.